why Bristol-Myers Squibb Co [BMY] is a Good Choice for Investors After New Price Target of $56.05
Bristol-Myers Squibb Co [NYSE: BMY] price surged by 1.94 percent to reach at $0.96. The one-year BMY stock forecast points to a potential upside of 9.78. The average equity rating for BMY stock is currently 2.64, trading closer to a bullish pattern in the stock